Interferon beta 1, an intermediate in the tumor necrosis factor alpha- induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression by unknown
INTERFERON 01, AN INTERMEDIATE IN THE TUMOR
NECROSIS FACTOR a-INDUCED INCREASED MHC CLASS I
EXPRESSION AND AN AUTOCRINE REGULATOR OF THE
CONSTITUTIVE MHC CLASS I EXPRESSION
BY J. F. M. LEEUWENBERG,* J. VAN DAMME,t G. M. A. A. JEUNHOMME,*
AND W. A. BUURMAN*
From the *Department ofSurgery, Biomedical Center, University ofLimburg,
Maastricht, The Netherlands; and the $Rega Institutefor Medical Microbiology, University of
Leuven, B-3000, Leuven, Belgium
In inflammatory reactions an increased expression ofHLA class I and class II
antigens is observed (1). This enhanced expression is expected to play a role in
the activation of both MHC class I- and class II-restricted Tcells. In vitro, the
mediators interferon ,8 (IFN-0), tumor necrosis factor a (TNF-a), and IFN-y
induce an increase in the MHC class I expression on human umbilical venal
endothelial (HUVE) cells and on human fibroblasts(2). Recombinant TNF-a has
been shown to increase the mRNA level and the surface expression of MHC
class I antigensvia a newlysynthesizedproteinintermediate, aswasdemonstrated
in experiments using a protein synthesis inhibitor (2). A candidate for this
intermediate is IFN-#l, since IFN-01 induces an increase in MHC class I expres-
sionon HUVE cellsandon human fibroblasts (2). Ithas been suggested, however,
that IFN-,B2 is the possible intermediate responsible for theincreased MHC class
I expression induced by TNFa (3).
We studied the putative role of IFN-#l in the increase in MHC class I
expression and the antiviral activity induced by TNF-a on HUVE cells and on
human fibroblasts. Our results demonstrate that IFN-,S1 plays the major role in
the rTNF-a-mediated increase in MHC class I expression and the antiviral
activity. Furthermore, it was shown that IFN-#l is involved in the autocrine
regulation ofthe constitutive MHC class I expression on HUVE cellsand human
fibroblasts.
Materials and Methods
BriefDefinitive Report
Cells.
￿
HUVE cells were isolated by selective collagenase digestion of the umbilical
vein. The cells were cultured in fibronectin-coated tissue culture flasks in RPMI 1640
(Gibco Europe, Paisley, Scotland), supplemented with 20% heat-inactivated human serum,
50 ug/ml heparin, endothelial cell growth supplement (30 ug/ml; Collaborative Research,
Lexington, MA), and antibiotics. Human fibroblastswere cultured in RPMI 1640 supple-
mented with 10% heat inactivatedFCS and antibiotics.
Reagents. rTNF-a was kindly provided by Dr. F. Frickel (Knoll Ag, Ludwigshafen,
Federal Republic of Germany) in cooperation with Biogen (Geneva, Switzerland). rIFN-
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,B1 was kindly provided by Prof. Bujard (Hoffman-LaRoche, Basel, Switzerland), and did
not show hybridoma growth factor activity at antiviral doses as high as 1,000 U/ml. The
26 kD protein, also designated as hybridoma growth factor (HGF) (4), or IFN-,B2 (5) or
BSF-2 (B cell stimulatory factor) (6) was obtained from MG-63 osteosarcoma cells induced
with IL-1 and purified by adsorption to controlled-pore glass beads and by antibody
chromatography to a specific activity of30 x 106 26-kD U/mg(manuscript in preparation).
One unit of 26 kD protein was defined as the amount required to obtain half-maximal
growth of factor-dependent hybridoma cells. The biologic activity of the 26 kD prepara-
tions used in our experiments showed 250,000 U/ml ofhybridoma growth factor activity,
while <10 U/ml of antiviral activity could be detected. Furthermore, rBSF-2 (6), kindly
provided by Prof. T. Hirano (Osaka, Japan) was used.
Antisera.
￿
An anti-TNF-a antiserum with TNF-a-neutralizing capacity was obtained by
immunizing rabbits with human rTNF-a. The antiserum showed a specific reaction in
immunoblot with a 17 kD product in macrophages corresponding with the reaction with
rTNF-a. Anti-IFN-ft1 was obtained by immunizing a goat with highly purified IFN-,B1
(108 U/mg); this antiserum had a neutralizing titer of more than 1 :500,000 against IFN-
,#1 (10 U/ml), but virtually no activity against 26 kD protein (titer <1/100). Rabbit anti-
dog IgG was purchased from Miles Laboratories, Elkhart, IN.
Induction and Detection ofMHCClass I Antigens.
￿
Cells were incubated for 4 din culture
medium supplemented with the reagents in the concentrations as indicated. Mixtures of
reagents with antibodies were preincubated for 4 h before adding them to the cells.
The expression of MHC antigens was studied with an indirect immunofluorescence
technique. MHC class I antigens were quantitated by staining with mAb W6/32, followed
by incubation with FITC-labeled antiserum against mouse Ig. Fluorescence was assessed
with a FACS IV cell sorter. The data were expressed in relative fluorescence intensity
units (RFI), according to the formula: RFI =
￿
10
[0 .0198 A(experimental cells)]/
10
[0.0198 A(control cello 1) ^-
The factor 0.0198 represents conversion of log to linear fluorescence distributions;
A(experimental cells) and A(control cells) being the difference in modal log green fluores-
cence channel between cells, with and without mAb anti-class 1.
Assayfor Antiviral Activity.
￿
Antiviral activity of rTNF-a, rIFN-,81, and 26 kD protein
was determined on diploid fibroblasts and on HUVE cells using a cytopathic effect
reduction assay. Vesicular stomatitis virus was used as a challenge and cells were stained
with crystal violet to measure cytopathic effect. The potency of IFN-,B1 was expressed in
international units (U/ml).
Results
rTNF-a Induces an Increase in MHC Class I Expression on HUVE Cells and on
Human FibroblastsviaIFN-ft1. Subconfluent HUVE cellsand human fibroblasts
were cultured for 4 d with different concentrations of rTNF-a in the presence
or absence ofeither an antiserum specifically directed against IFN-,81, or against
rTNF-a (data not given). As a control an irrelevant rabbit anti-dog IgG anti-
serum was included (data not given). The data in Table I demonstrate that the
increase in MHC class I expression is dependent upon the concentration of
rTNF-a, reaching a plateau value at ^-30 ng/ml rTNF-a. The plateau value
varied per experiment from 1 .7 to 4.2 on HUVE cells and human fibroblasts as
expressed in RFI units. The addition ofanti-IFN-,8l to the cultures reduced this
increase markedly, suggesting that IFN-,B1 in the intermediate messenger. The
inhibition of the rTNF-a-induced increase in MHC class I expression by anti-
IFN-,B1 cannot be attributed to a nonspecific serum effect, since an anti-dog IgG
serum did not interfere with the MHC class I expression. Antiserum directed
against rTNF-a blocked the rTNF-a effect, indicating that the increase in MHC
class I expression is attributable to rTNF-a and not to possible contaminants
present in the preparation.
Effect of rIFN-,BI and IFN-,62 (26 kD and rBSF-2) on MHC Class I Expres-1182
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TABLE I
Effect ofAnti-IFN-01 on the rTNF-a-induced Increase in MHC Class I Expression on HWE
Cells and Human Fibroblasts
HUVE cells
￿
Fibroblasts
Data are expressed in RFI as described in Materials and Methods.
* Subconfluent cells were cultured for 4 d in the absence (-) or presence (+) of antiserum directed against IFN-
#1 .
TABLE II
Effect of rIFN-/31 and IFN-(32 (26 hD and rBSF-2) on MHC ClassIExpression in
Subconfuent GrowingHWE Cells and Fibroblasts
* IFN-01 is expressed in antiviral units per milliliter; 1 U/ml = 0.5 pM; IFN-02 is expressed in hybridoma growth-
promoting units: 26 kD, 1 U/ml = 0.4 pM; rBSF-2, 1 U/ml = 0.3 pM.
Data are expressed in RFI (see Materials and Methods).
sion.
￿
IFN-01 and IFN-,Q2 (either highly purified 26 kD or rBSF-2) were tested
for their effect on MHC class I expression on HUVE cells and on human
fibroblasts. In Table II the results show that IFN-#1 increases the MHC class I
expression. Although purified natural IFN-R2 (26 kD) showed inconsistently a
slight effect on the expression of MHC, highly purified IFN-,B2 (rBSF-2) did not
enhance MHC class I expression even at high concentrations.
Antiviral Effect of rTNF-a on HWE Cells and on Human Fibroblasts Is Abrogated
by Anti-IFN-f l. The role of IFN-,B1 and the 26 kD protein in the antiviral effect
of rTNF-a and IL-I on fibroblastoid cells has been investigated in a separate
study (7). In view of our findings with rTNF-a on MHC class I expression in
HUVE cells and fibroblasts, we also studied the possible antiviral activity of
rTNF-a on thosecells. Table III shows that rTNF-a and IFN-#1 have an antiviral
effect on HUVE cells, similar to that on diploid fibroblasts. Moreover, the
antiviral activity of rTNF-a on HUVE cells was also completely neutralizable by
antibody against IFN-(31 . This finding indicates that IFN-01 is an important
mediator of the antiviral effect of rTNF-a in the same cell systems in which it
plays a role in rTNF-a-induced MHC class I expression.
IFN-01 Plays a Role in the Constitutive MHC Class I Expression.
￿
As shown in
Table 1, anti-IFN-01 not only inhibited the rTNF-a effect, but it also caused a
decrease in the class I expression that occurs in the absence of rTNF-a. This
IFN*
U/m1
IFN-01
HUVE cells
26 kD rBSF-2 IFN-01
Fibroblasts
26 kD rBSF-2
10 1 .41: - - 1.7 - -
50 1.8 1 .0 1 .0 1.7 1.0 1 .0
150 2.0 1 .0 1 .0 2.3 1.1 0.9
450 1 .6 1 .2 0.9 2.2 1 .4 1 .0
1,350 - 1 .1 0.8 - 1.5 1 .0
4,050 - 1 .3 - - 1.2 -
'FNF-a
ng/ml
Exp. I Exp. 2 Exp. 3 Exp. 4
0 1 .0 1 .0 1 .0 0.7 1.0 0.9 1 .0 0.9
3 1 .8 1 .3 1 .6 0.9 1.7 0.9 1 .8 1.0
10 3.3 1 .5 1 .9 0.8 1.7 1 .1 2.2 1.2
30 3.5 1 .4 1 .9 1 .1 4.0 0.9 4.2 1.6LEEUWENBERG ET AL.
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TABLE III
Antiviral Effect of rTNF-a on Diploid Fibroblasts and HWE Cells and Its Neutralization by
Specific Antibody against IFN-fl]
Cytokine tested
Antibody added
￿
Antiviral activity on:
TNF-a (1,400 ng/ml)
IFN-fl]
A constant amount of antiserum was added to each dilution of the antiviral assay, and reaction mixtures were
incubated at 37°C for 2 h before transfer to the test cells.
TABLE IV
Effect ofrIFN-#1 and Anti-IFN-,BI on MHC Class I Expression by Confluent HWE Cells and
Fibroblasts
Mean ±SE
￿
1 .66±0.25
￿
0.6±0.05
￿
1.58±0.18
￿
0.7±0.07
300 U/ml rIFN-#, was added to the cultures.
* Antiserum directed against IFN-#1 was incubated at a final dilution of 1 :3,000.
prompted us to study the role of autocrine IFN-,B1 in the regulation of the
constitutive MHC class I expression. A pilot experiment demonstrated that the
effect ofanti-IFN-al on the constitutive MHC class I expression wasmost marked
in aged cells, i.e., cells kept in culture in the same medium for several days after
confluency was reached. Therefore, we compared the influence of exogenous
added rIFN-,B1 and anti-IFN-,#1 on confluent cells without changing the culture
medium. Both in fibroblasts and in HUVE cells, anti-IFN-S1 added to confluent
cultures reduced the MHC class I expression to ^"65% ofthe normal spontaneous
expression (Table IV), indicating that IFN-#1 is involved in the expression of
the constitutive MHC class I antigens on these cells. Addition ofrIFN-,61 resulted
in an increase of MHC class I expression to ^"160% of spontaneous expression
(Table IV). Control antibodies did not affect the IFN-,B1-induced increase in
MHC class I expression (data not shown).
Discussion
In accordance with others (2, 8), we show here that rTNF-a induces an
increase in MHC class I expression on HUVE cells and human fibroblasts. This
increase can be inhibited by antibodies specifically neutralizing human IFN-#1 .
Exp.
HUVE
rIFN-#l*
cells
Anti-IFN-#1* rIFN-#1
Fibroblasts
Anti-IFN-#1
1 1 .1 0.6 1.7 0.6
2 1 .6 0.6 2.0 0.5
3 2.6 0.8 1.2 0.7
4 1 .5 0.5 1.9 0.9
5 1 .5 0.5 1.1 0.8
Specificity
Recip-
roca
rocsl
tion
Fibroblasts
U/m1
H VE e
- - 1,000 640
Anti-TNF-a 50 <32 64
Anti-IFN-#l 3,000 <32 <10
- - 10,000 6,400
Anti-TNF-a 50 16,000 5,000
Anti-IFN-01 3,000 10 <101184
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Similarly, the antiviral activity mediated by rTNF-a that is shown to occur not
only in tumor cells (9, 10) and in fibroblasts (3, 7), but also in endothelial cells
can be completely abrogated by anti-IFN-,81. These results indicate that IFN-(31
is involved in the rTNF-a-mediated increase in MHC class I expression and
antiviral activity.
Addition of rIFN-,81 to HUVE cells and fibroblasts increased the MHC class I
expression . Antiserum directed against IFN-,81 caused a decrease of the MHC
class I expression by the cells not treated with rTNF-a or rIFN-,81 . This effect
was most pronounced in confluent cultured cells, probably because ofan internal
pool of IFN-fll . Autocrine IFN-,81 is apparently involved in the constitutive
MHC class I expression. Thus, the mechanism by which rTNF-a acts upon the
cells is not a new mechanism, but rather an enhancement of the physiological
autocrine regulation of HLA gene expression.
Collins et al. (2) described that the effect of rTNF-a on the MHC class I
expression wasregulated viaa mediator. Our studiesstrongly indicatedthat IFN-
,81 is the mediator responsible for this process. Others, however, suggested IFN-
,82 to be the intermediate (3, 8). They observed high levels of IFN-02 mRNA,
whereas they failed to detect IFN-,81 mRNA in TNF-a-treated fibroblasts.
Experiments with IFN-,82 (26 kD protein and rBSF-2) showed that even high
doses (>4,000 U/ml) did not or only very slightly affect the MHC class I
expression and lacked antiviral activity on HUVE cells and fibroblasts. Although
the possibility cannot be excluded that IFN-,82/26 kD/rBSF-2 protein plays a
limited role in the rTNF-a-mediated increase in MHC class I expression and
antiviral activity, our results indicate that IFN-,B1 is the major factor responsible
for these effects ofrTNF-a. Autocrine secretion of IFN-S by the tumor cell line
U937 triggers the expression of MHC class I antigens (11). Our data provide
evidence that this phenomenon is not restricted to that monocytic tumor cell
line, but is also functional in normal HUVE cells and human fibroblasts. It is
likely that the constitutive MHC class I expression in various cell types is at least
in part regulated via autocrine IFN-/31. The autocrine regulation of MHC class
I antigen expression combined with virus protection is a functional strategy,
since the MHC class I expression plays a role in the recognition and destruction
ofvirus-infected cells by MHC class I-restricted T lymphocytes, and simultane-
ously the IFN-,81 protects the cell against virus infection. Furthermore, theTNF-
a-induced upregulation ofthe MHC class I expression may be ofimportance for
the recognition of tumor cells by T lymphocytes. The absence or reduction in
number ofMHC class I molecules (12) is a mechanism by which tumor cells may
escape from destruction by the immune system. Alternatively, the enhancement
of MHC class I expression may rescue such tumor cells from the activity of
natural killer cells, since these cells were suggested to preferentially kill cells with
a deleted or reduced expression of MHC antigen (13). Thus, TNF-a and the
interferons provide the cells with virus protection as well aswith enhanced MHC
class I expression, resulting in a double surveillance.
Summary
In conclusion, our observations indicate that the constitutive MHC class I
expression is regulated by autocrine production of IFN-#1 . TNF-a acts as anLEEUWENBERG ET AL.
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enhancer of the autocrine production of IFN-,BI, and consequently as an en-
hancer of the MHC class I expression and viral protection.
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